Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2021

01-01-2021 | Escherichia Coli | Original Article

Commonality of adherent-invasive Escherichia coli isolated from patients with extraintestinal infections, healthy individuals and the environment

Authors: D. J. Astley, N. Masters, A. Kuballa, M. Katouli

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Adherent-invasive Escherichia coli (AIEC) has been implicated as a microbiological factor in inflammatory bowel disease (IBD) pathogenesis. These strains are defined by their ability to adhere to and invade intestinal epithelial cells, and to survive and replicate in macrophages. We postulated that AIEC strains may commonly inhabit the gut of healthy individuals (HI), cause extraintestinal infections, and be found in sewage treatment plants (STP) and surface waters (SW). A total of 808 E. coli strains isolated from HI; patients with community-acquired urinary tract infection (CA-UTI), septicaemia and urosepsis; STP; and SW, showing a diffuse adhesion pattern to Caco-2 cells were included in this study. Typing of the strains using a combination of RAPD-PCR and PhPlate fingerprinting grouped them into 48 common clones (CCs). Representatives of each CC were tested for the ability to invade Caco-2 cells, survive and replicate in macrophages, and for the presence of six virulence genes commonly found among AIEC strains. Twenty CCs were deemed AIEC based on their ability to survive and replicate in macrophages, while encoding htrA, dsbA and clbA genes. These CCs primarily originated from HI and CA-UTI patients but were also detected in secondary locations including STP and SW. Strains lacking intramacrophagic survival and replication abilities were regarded as diffusely adhering E. coli (DAEC). Certain clones of AIEC are common in the gut of HI whilst promoting CA-UTI. The survival and persistence of AIEC in STP and SW may have serious public health ramifications for individuals predisposed to IBD.
Appendix
Available only for authorised users
Literature
9.
go back to reference Martinez-Medina M, Aldeguer X, Lopez-Siles M, González-Huix F, López-Oliu C, Dahbi G, Blanco JE, Blanco J, Garcia-Gil LJ, Darfeuille-Michaud A (2009) Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn’s disease. Inflamm Bowel Dis 15(6):872–882. https://doi.org/10.1002/ibd.20860CrossRefPubMed Martinez-Medina M, Aldeguer X, Lopez-Siles M, González-Huix F, López-Oliu C, Dahbi G, Blanco JE, Blanco J, Garcia-Gil LJ, Darfeuille-Michaud A (2009) Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn’s disease. Inflamm Bowel Dis 15(6):872–882. https://​doi.​org/​10.​1002/​ibd.​20860CrossRefPubMed
22.
go back to reference Dreux N, Denizot J, Martinez-Medina M, Mellman A, Billig M, Kisiela D, Chattopdhyay S, Sokurenko E, Neut C, Gower-Rousseau C (2013) Point mutations in FimH adhesin Crohn’s disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog 9:e1003141CrossRef Dreux N, Denizot J, Martinez-Medina M, Mellman A, Billig M, Kisiela D, Chattopdhyay S, Sokurenko E, Neut C, Gower-Rousseau C (2013) Point mutations in FimH adhesin Crohn’s disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog 9:e1003141CrossRef
31.
go back to reference Schlager TA, Whittam TS, Hendley JO, Bhang JL, Wobbe CL, Stapleton A (2003) Variation in frequency of the virulence-factor gene in Escherichia coli clones colonising the stools and urinary tracts of healthy prepubertal girls. J Infect Dis 188:1059–1064. https://doi.org/10.1086/377643CrossRefPubMed Schlager TA, Whittam TS, Hendley JO, Bhang JL, Wobbe CL, Stapleton A (2003) Variation in frequency of the virulence-factor gene in Escherichia coli clones colonising the stools and urinary tracts of healthy prepubertal girls. J Infect Dis 188:1059–1064. https://​doi.​org/​10.​1086/​377643CrossRefPubMed
33.
go back to reference Anastasi EM, Matthews B, Gundogdu A, Vollmerhausen TL, Ramos NL, Stratton H, Ahmed W, Katouli M (2010) Prevalence and persistence of Escherichia coli strains with uropathogenic virulence characteristics in sewage treatment plants. Appl Environ Microbiol 78:5536–5541. https://doi.org/10.1128/AEM.00657-12CrossRef Anastasi EM, Matthews B, Gundogdu A, Vollmerhausen TL, Ramos NL, Stratton H, Ahmed W, Katouli M (2010) Prevalence and persistence of Escherichia coli strains with uropathogenic virulence characteristics in sewage treatment plants. Appl Environ Microbiol 78:5536–5541. https://​doi.​org/​10.​1128/​AEM.​00657-12CrossRef
42.
go back to reference Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, Knight P, Codling C, Marchesi JR, Winstanley C (2013) Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut:gutjnl-2013 Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, Knight P, Codling C, Marchesi JR, Winstanley C (2013) Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut:gutjnl-2013
Metadata
Title
Commonality of adherent-invasive Escherichia coli isolated from patients with extraintestinal infections, healthy individuals and the environment
Authors
D. J. Astley
N. Masters
A. Kuballa
M. Katouli
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-04066-5

Other articles of this Issue 1/2021

European Journal of Clinical Microbiology & Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.